Nutritional supplementations have been widely used as adjunctive treatments for
schizophrenia. However, among these supplementations, of which the most beneficial is …

There is a high rate of misdiagnosis between major depressive disorder (MDD) and bipolar
disorder (BD) in clinical practice. Our previous work provided suggestive evidence for brain …

Increasing evidence indicates that immune inflammatory processes, especially autoimmune
reaction, should be considered in the pathophysiology of schizophrenia and aggressive …

BackgroundEarly identification of patients with bipolar disorder during their first depressive
episode is beneficial to the outcome of the disorder and treatment, but traditionally this has …

Background Immune system dysregulation is critical in the physiopathology of major
depressive disorder (MDD) and bipolar disorder (BD). However, it is unclear whether both …

Background: Hyodeoxycholic acid (HDCA) is a natural secondary bile acid with enormous
pharmacological effects, such as modulating inflammation in neuron. However, whether …

The association between BDNF gene functional Val66Met polymorphism rs6265 and the
schizophrenia is far from being consistent. In addition to the heterogeneous in schizophrenia …

Glial damage and immune dysfunction are involved in pathogenesis of schizophrenia.
However, interaction between glial damage and immune dysfunction in schizophrenia is …

Atypical antipsychotics are highly effective antischizophrenic medications but their clinical
utility is limited by adverse metabolic sequelae. We investigated whether upregulation of …

Abstract Single Nucleotide Polymorphic (SNP) variations of proinflammatory cytokines such
as Tumor Necrosis Factor-α (TNF-α) have been reported to be closely associated with the …